Antimicrobial Susceptibility Testing of Two Lawsonia intracellularis Isolates Associated with Proliferative Hemorrhagic Enteropathy and Porcine Intestinal Adenomatosis in South Korea (cid:1)
暂无分享,去创建一个
Ji Youn Lee | I. Choi | Joong-Bok Lee | A. Kim | H. Yeh | B. Kang | J. Yeh | Jeong-Min Hwang | Jong-Man Kim | Ji‐hye Lee
[1] R. Singer,et al. In vitro antimicrobial activity against 10 North American and European Lawsonia intracellularis isolates. , 2009, Veterinary microbiology.
[2] G. Shurson,et al. Effect of including distillers dried grains with solubles in the diet, with or without antimicrobial regimen, on the ability of growing pigs to resist a Lawsonia intracellularis challenge. , 2006, Journal of animal science.
[3] Chang-Seon Song,et al. Isolation of Lawsonia intracellularis in Korea and reproduction of proliferative enteropathy in pigs and hamsters. , 2006, The Journal of veterinary medical science.
[4] C. Kyriakis,et al. First experience on the effect of in-feed lincomycin for the control of proliferative enteropathy in growing pigs. , 2006, Journal of veterinary medicine. A, Physiology, pathology, clinical medicine.
[5] D. Suh,et al. Prevalence of Lawsonia intracellularis, Brachyspira hyodysenteriae and Salmonella in swine herds. , 2005, Journal of veterinary science.
[6] J. Bradford,et al. Evaluation of lincomycin in drinking water for treatment of induced porcine proliferative enteropathy using a Swine challenge model. , 2004, Veterinary therapeutics : research in applied veterinary medicine.
[7] C. Gebhart,et al. Onset and duration of fecal shedding, cell-mediated and humoral immune responses in pigs after challenge with a pathogenic isolate or attenuated vaccine strain of Lawsonia intracellularis. , 2003, Veterinary microbiology.
[8] T. Kim,et al. Prevalence of porcine proliferative enteropathy and its control with tylosin in Korea. , 2001, Journal of veterinary science.
[9] C. Gebhart,et al. Efficacy of intramuscular tylosin for the treatment and control of porcine proliferative enteropathy caused by Lawsonia intracellularis. , 2001, Veterinary therapeutics : research in applied veterinary medicine.
[10] C. Gebhart,et al. Proliferative enteropathy. , 2019, Journal of comparative pathology.
[11] J. Butts,et al. In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected vero cell monolayers. , 2000, The Journal of antimicrobial chemotherapy.
[12] S. McOrist,et al. Therapeutic efficacy of water-soluble lincomycin-spectinomycin powder against porcine proliferative enteropathy in a European field study , 2000, The Veterinary Record.
[13] H. Kroger,et al. Oral administration of tylosin phosphate for treatment and prevention of proliferative enteropathy in pigs. , 1997, American journal of veterinary research.
[14] D. Miller,et al. Treatment and prevention of porcine proliferative enteropathy with oral tiamulin , 1996, Veterinary Record.
[15] J. Gnarpe,et al. In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae , 1996, Antimicrobial agents and chemotherapy.
[16] S. Barns,et al. Characterization of Lawsonia intracellularis gen. nov., sp. nov., the obligately intracellular bacterium of porcine proliferative enteropathy. , 1995, International journal of systematic bacteriology.
[17] S. McOrist,et al. Antimicrobial susceptibility of ileal symbiont intracellularis isolated from pigs with proliferative enteropathy , 1995, Journal of clinical microbiology.